microdosing glp 1 drugs GLP-1s: Safety, Dosage, Side Effects, and Results GLP-1 Microdosing vs. Standard Dosing:

10.1161/CIRCULATIONAHA.112.096479 [DOI] [PubMed] [Google Scholar] 175.Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, et al

Drugs 32 , 355359 (2023)

Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with type 2 diabetes: A randomized clinical trial

Quick Answer: GLP-1 receptor agonists do not directly cause eye damage but may worsen diabetic retinopathy in patients with pre-existing retinal disease who experience rapid blood glucose reductions

Most commonly, this means insulin through multiple daily injections or an insulin pump, though some providers use metformin as an adjunct since its generally considered safe in pregnancy